Hidden amyloid in heart valves: a new clue in aortic stenosis?
NCT ID NCT04636684
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is examining heart valve tissue from 100 people undergoing surgery for aortic stenosis to see how often ATTR amyloid deposits are present. Researchers will use mass spectrometry to identify the type of amyloid. The goal is to better understand the link between amyloidosis and aortic valve disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could clarify how often ATTR amyloidosis affects heart valves, potentially guiding future diagnosis or treatment approaches.
- What could go wrong
- This is an observational study with no treatment being tested. It only looks at tissue samples and does not directly improve patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
university hospital center Toulouse
RECRUITINGToulouse, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A hidden warning in your wrist? surgery may reveal heart risk
- Can a daily pill keep a rare heart disease in check for the long haul?
- Heart drug acoramidis tested for Long-Term cardiac repair in rare amyloidosis
- Heart imaging may reveal hidden clues in rare heart disease
- App-Based diet tracking tested in rare disease
- Wrist MRI may spot hidden amyloid clumps without needles